Pim Bouwmans (P.)

Research profile

Nephrology

Palliative Care

Pharmacoepidemiology

COVID-19 pandemic

Research projects

Timely palliative care in dialysis patients – a new approach (TIPTOPdialysis): https://projecten.zonmw.nl/nl/project/tijdige-palliatieve-zorg-voor-dialysepatienten-een-nieuwe-benadering

Impact of COVID-19 protective measures and shielding in vulnerable patients with kidney failure (RECOVAC): https://projecten.zonmw.nl/nl/project/invloed-van-beschermende-covid-19-maatregelen-en-isolatie-op-kwetsbare-patienten-met

Renal patients COVID-19 vaccination (RECOVAC) consortium: https://projecten.zonmw.nl/en/project/renal-patients-covid-19-vaccination-recovac-consortium 


 

Key publications
  • Bouwmans, P., Messchendorp, A. L., Sanders, J. S., Hilbrands, L., Reinders, M. E. J., Vart, P., Bemelman, F. J., Abrahams, A. C., van den Dorpel, M. A., Ten Dam, M. A., de Vries, A. P. J., Rispens, T., Steenhuis, M., Gansevoort, R. T., Hemmelder, M. H., & RECOVAC Collaborators (2022). Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study. Bmc Nephrology, 23(1), Article 55. https://doi.org/10.1186/s12882-022-02680-3
    More information about this publication
  • Bouwmans, P., Brandts, L., Hilbrands, L. B., Duivenvoorden, R., Vart, P., Franssen, C. F. M., Covic, A., Islam, M., Rabaté, C., Jager, K. J., Noordzij, M., Gansevoort, R. T., Hemmelder, M. H., & ERACODA Collaborators (2022). The clinical frailty scale as a triage tool for ICU admission of dialysis patients with COVID-19 - An ERACODA analysis. Nephrology Dialysis Transplantation, 37(11), 2264-2274. https://doi.org/10.1093/ndt/gfac246
    More information about this publication
  • Frolke, S. C., Bouwmans, P., Messchendorp, L., Geerlings, S. E., Hemmelder, M. H., Gansevoort, R. T., Hilbrands, L. B., Reinders, M. E. J., Sanders, J. S. F., Bemelman, F. J., Peters-Sengers, H., & RECOVAC Collaborators (2022). Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients. Transplantation Direct, 8(11), Article e1397. https://doi.org/10.1097/TXD.0000000000001397
    More information about this publication
  • Meziyerh, S., Bouwmans, P., van Gelder, T., van der Helm, D., Messchendorp, L., van der Boog, P. J. M., de Fijter, J. W., Moes, D. J. A. R., de Vries, A. P. J., & RECOVAC Collaborators (2023). Mycophenolic acid exposure determines antibody formation following SARS-CoV-2 vaccination in kidney transplant recipients: a nested cohort study. Clinical Pharmacology & Therapeutics, 114(1), 118-126. https://doi.org/10.1002/cpt.2872
    More information about this publication
  • Bouwmans, P., Messchendorp, A. L., Imhof, C., Sanders, J.-S. F., Hilbrands, L. B., Reinders, M. E. J., Vart, P., Bemelman, F. J., Abrahams, A. C., van den Dorpel, R. M. A., Ten Dam, M. A. G. J., de Vries, A. P. J., Rispens, T., Steenhuis, M., Gansevoort, R. T., Hemmelder, M. H., & RECOVAC Collaborators (2023). Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy. Clinical Kidney Journal, 16(3), 528-540. https://doi.org/10.1093/ckj/sfac249
    More information about this publication
  • Bouwmans, P., Skalli, Z., Vernooij, R. W. M., Hemmelder, M. H., Konijn, W. S., Lips, J., Mulder, J., Bonenkamp, A. A., van Jaarsveld, B. C., Abrahams, A. C., & DOMESTICO Study Group (2023). Differences in mental health status during the COVID-19 pandemic between patients undergoing in-center hemodialysis and peritoneal dialysis. Journal of Nephrology, 36(7), 2037-2046. https://doi.org/10.1007/s40620-023-01747-0
    More information about this publication
  • Bouwmans, P., Malahe, S. R. K., Messchendorp, A. L., Vart, P., Imhof, C., Sanders, J.-S., Gansevoort, R. T., de Vries, A. P. J., Abrahams, A. C., Bemelman, F. J., Vervoort, J. P. M., Hilbrands, L., Ten Dam, M. A. G. J., van den Dorpel, R. M. A., Rispens, T., Steenhuis, M., Reinders, M. E. J., Hemmelder, M. H., & RECOVAC Consortium (2024). Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: a nested case-control study. International Journal of Infectious Diseases, 142, Article 106990. https://doi.org/10.1016/j.ijid.2024.106990
    More information about this publication
  • Frölke, S. C., Bouwmans, P., Messchendorp, A. L., Vervoort, J. P. M., Abrahams, A. C., de Vries, A. P. J., Nieuwkerk, P. T., Hemmelder, M. H., Gansevoort, R. T., Hilbrands, L. B., Reinders, M. E. J., Sanders, J. S. F., Bemelman, F. J., Geerlings, S. E., Imhof, C., Idzinga, C., Siegert, C., Baan, C. C., Konings, C. J. A. M., ... RECOVAC Collaborators (2023). Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study. EClinicalMedicine, 62(1), Article 102103. https://doi.org/10.1016/j.eclinm.2023.102103
    More information about this publication
  • Messchendorp, A. L., Zaeck, L. M., Bouwmans, P., van den Broek, D. A. J., Froelke, S. C., Geers, D., Imhof, C., Malahe, S. R. K., Schmitz, K. S., Reinders, J., Visscher, F. E., Baan, C. C., Bemelman, F. J., Gansevoort, R. T., Geurtsvankessel, C. H., Hemmelder, M. H., Hilbrands, L. B., Kaellmark, H., Kapetanovic, M. C., ... RECOVAC Collaborators (2025). Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial. Clinical Infectious Diseases, Article ciaf107. Advance online publication. https://doi.org/10.1093/cid/ciaf107
    More information about this publication
  • Messchendorp, A. L., Sanders, J.-S. F., Abrahams, A. C., Bemelman, F. J., Bouwmans, P., van den Dorpel, R. M. A., Hilbrands, L. B., Imhof, C., Reinders, M. E. J., Rispens, T., Steenhuis, M., Ten Dam, M. A. G. J., Vart, P., de Vries, A. P. J., Hemmelder, M. H., Gansevoort, R. T., & RECOVAC Collaborators (2024). Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients. Viruses, 16(1), Article 114. https://doi.org/10.3390/v16010114
    More information about this publication